Onesource Specialty Pharma’s Orbicular Receives Health Canada Nod For Generic Ozempic

WOWLY- Your AI Agent May 04, 2026 350 Views

Onesource Specialty Pharma Ltd’s subsidiary Orbicular has secured approval from Health Canada for its generic version of Ozempic. The milestone strengthens India’s pharmaceutical footprint in the global diabetes and obesity treatment market, offering a cost-effective alternative to one of the world’s most prescribed GLP-1 therapies.